Cited by 358Retinal Diseases and TreatmentsComplement system in diseasesAntioxidant Activity and Oxidative Stress

Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium

Open access
Zhou, Jilin, Jang, Young Pyo, Kim, So Ra, Sparrow, Janet R.·2006·Proceedings of the National Academy of Sciences

Abstract

Recent studies have implicated local inflammation and activation of complement amongst the processes involved in the pathogenesis of age-related macular degeneration (AMD). Several lines of investigation also indicate that bis-retinoid pigments, such as A2E, that accumulate as lipofuscin in retinal pigment epithelial (RPE) cells, contribute to the disease process. In an investigation of a potential trigger for complement activation in AMD, we explored the notion that the complex mixture of products resulting from photooxidation of A2E might include a range of fragments that could be recognized by the complement system as “foreign” and that could serve to activate the complement system, leading to low-grade inflammation. To this end, we established an in vitro assay by using human serum as a source of complement, and we measured products of C3 activation by enzyme immunoassay. Accordingly, we found that the C3 split products inactivated C3b (iC3b) and C3a were elevated in serum, overlying ARPE-19 cells that had accumulated A2E and were irradiated to induce A2E photooxidation. Precoating of microtiter plates with two species of oxidized A2E, peroxy-A2E, and furano-A2E, followed by incubation with serum, also activated complement. We suggest that products of the photooxidation of bis-retinoid lipofuscin pigments in RPE cells could serve as a trigger for the complement system, a trigger than would predispose the macula to disease and that, over time, could contribute to chronic inflammation. These findings link four factors that have been posited as being associated with AMD: inflammation, oxidative damage, drusen, and RPE lipofuscin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0604255103

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. [3]Curcio CA, Millican CL, Bailey T, Kruth HS. Invest Ophthalmol Vis Sci. 2001;42:265–274. [PubMed] [Google Scholar]
  2. [16]Law SKA, Reid KBM. Complement. Oxford: Oxford Univ Press; 1995. [Google Scholar]
  3. [27]Delori FC, Goger DG, Dorey CK. Invest Ophthalmol Vis Sci. 2001;42:1855–1866. [PubMed] [Google Scholar]
  4. [28]Sakai N, Decatur J, Nakanishi K, Eldred GE. J Am Chem Soc. 1996;118:1559–1560. [Google Scholar]
  5. [34]Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Invest Ophthalmol Vis Sci. 2002;43:1222–1227. [PubMed] [Google Scholar]
  6. [45]Cruickshanks KJ, Klein R, Klein BEK, Nondahl DM. Arch Ophthalmol. 2001;119:246–250. [PubMed] [Google Scholar]
  7. [56]Dentchev T, Milam AH, Lee VMY, Trojanowski JQ, Dunaief JL. Mol Vis. 2003;9:184–190. [PubMed] [Google Scholar]
  8. [59]Turro NJ, Chow M-F, Rigaudyo J. J Am Chem Soc. 1981;103:7218–7222. [Google Scholar]
  9. [60]Sparrow JR, Parish CA, Hashimoto M, Nakanishi K. Invest Ophthalmol Vis Sci. 1999;40:2988–2995. [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Zhou, J., Jang, Y. P., Kim, S. R., & Sparrow, J. R.
Affiliations
  • Departments of *Ophthalmology and
  • Columbia University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2006-10-31
Volume
103
Issue
44
Pages
16182-16187
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2009256817
Cited by
358
References
63
Citations by year
2026: 6 · 2025: 15 · 2024: 8 · 2023: 11 · 2022: 12 · 2021: 24 · 2020: 19 · 2019: 10 · 2018: 15 · 2017: 10 · 2016: 11 · 2015: 28 · 2014: 24 · 2013: 27 · 2012: 33
FWCI
17.11
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Eye Institute (R01EY012951, EY 12951)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
Keywords
complement activation, A2E, lipofuscin, retinal pigment epithelium, age-related macular degeneration, photooxidation, iC3b, C3a, oxidative damage, drusen, inflammation
MeSH terms
Cell Line, Complement C3b, Epithelium, Furans, Humans, Lipofuscin, Oxidation-Reduction, Photochemistry, Pyridinium Compounds, Retinal Pigments, Retinoids, Mass Spectrometry, Molecular Structure, Complement C3a

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review